Published in J Clin Densitom on January 01, 2001
Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 3.11
Pediatric body composition analysis with dual-energy X-ray absorptiometry. Pediatr Radiol (2009) 1.91
Differences in bone microarchitecture between postmenopausal Chinese-American and white women. J Bone Miner Res (2011) 1.86
Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: explanation of a paradox. J Bone Miner Res (2009) 1.76
Precision and accuracy of measuring changes in bone mineral density by dual-energy X-ray absorptiometry. Osteoporos Int (2007) 1.48
Pediatric DXA: technique and interpretation. Pediatr Radiol (2006) 1.34
Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women. J Bone Miner Res (2011) 1.34
Automated registration of hip and spine for longitudinal QCT studies: integration with 3D densitometric and structural analysis. Bone (2005) 1.29
A referent bone mineral density database for Chinese American women. Osteoporos Int (2006) 1.05
Dual energy x-ray absorptiometry of the distal femur may be more reliable than the proximal tibia in spinal cord injury. Arch Phys Med Rehabil (2009) 1.01
A study of the long-term precision of dual-energy X-ray absorptiometry bone densitometers and implications for the validity of the least-significant-change calculation. Osteoporos Int (2006) 1.01
Special report on the official positions of the International Society for Clinical Densitometry. Osteoporos Int (2004) 1.00
Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. J Clin Endocrinol Metab (2014) 0.95
Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis. Osteoporos Int (2003) 0.94
Trabecular bone score is associated with volumetric bone density and microarchitecture as assessed by central QCT and HRpQCT in Chinese American and white women. J Clin Densitom (2013) 0.92
Calcaneal quantitative ultrasound as a determinant of bone health status: what properties of bone does it reflect? Int J Med Sci (2013) 0.91
Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation. J Clin Endocrinol Metab (2015) 0.87
A customized protocol to assess bone quality in the metacarpal head, metacarpal shaft and distal radius: a high resolution peripheral quantitative computed tomography precision study. BMC Musculoskelet Disord (2013) 0.86
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates. J Clin Endocrinol Metab (2016) 0.85
Reference values for bone mineral density in 12- to 18-year-old girls categorized by weight, race, and age. Pediatr Radiol (2004) 0.85
Precision of ¹⁸F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism. Osteoporos Int (2012) 0.84
Differences in age-related bone mass of proximal femur between Chinese women and different ethnic women in the United States. J Bone Miner Metab (2007) 0.84
The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women. J Bone Miner Metab (2009) 0.83
Low vitamin D levels have become less common in primary hyperparathyroidism. Osteoporos Int (2015) 0.83
Differences in precision in bone mineral density measured by SXA and DXA: the NOREPOS study. Eur J Epidemiol (2008) 0.82
Minimum sample size requirements for bone density precision assessment produce inconsistency in clinical monitoring. Osteoporos Int (2006) 0.80
Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women. J Clin Endocrinol Metab (2013) 0.80
Lean tissue mass and energy expenditure are retained in hypogonadal men with spinal cord injury after discontinuation of testosterone replacement therapy. J Spinal Cord Med (2014) 0.80
Determinants of bone mineral density in Chinese-American women. Osteoporos Int (2006) 0.79
Thyroid-stimulating hormone is significantly associated with bone health status in men. Int J Med Sci (2013) 0.79
Establishment of BMD reference curves at different skeletal sites in women, using a Cartesian coordinate numeration system. Osteoporos Int (2005) 0.79
Common mistakes in the clinical use of bone mineral density testing. Nat Clin Pract Rheumatol (2008) 0.78
A trabecular plate-like phenotype is overrepresented in Chinese-American versus Caucasian women. Osteoporos Int (2014) 0.78
The effect of weight and weight change on the long-term precision of spine and hip DXA measurements. Osteoporos Int (2010) 0.78
A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part II: 1-Yr Change, Long-Term Precision, and Least Significant Change. J Clin Densitom (2014) 0.78
Effects of the sample size of reference population on determining BMD reference curve and peak BMD and diagnosing osteoporosis. Osteoporos Int (2007) 0.77
Quality Control of DXA System and Precision Test of Radio-technologists. J Bone Metab (2014) 0.77
Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism. Osteoporos Int (2016) 0.77
Bisphosphonate Treatment in Osteoporosis: Optimal Duration of Therapy and the Incorporation of a Drug Holiday. HSS J (2015) 0.77
QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis. Osteoporos Int (2012) 0.77
Relationship of body surface area with bone density and its risk of osteoporosis at various skeletal regions in women of mainland China. Osteoporos Int (2004) 0.77
Ten-year prediction of osteoporosis from baseline bone mineral density: development of prognostic thresholds in healthy postmenopausal women. The Danish Osteoporosis Prevention Study. Osteoporos Int (2005) 0.77
Least significant changes and monitoring time intervals for high-resolution pQCT-derived bone outcomes in postmenopausal women. J Musculoskelet Neuronal Interact (2015) 0.77
Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. Prostate Cancer Prostatic Dis (2012) 0.77
Establishment of BMD reference databases for the diagnosis and evaluation of osteoporosis in central southern Chinese men. J Bone Miner Metab (2008) 0.77
Cross-sectional study of the association of body composition and physical fitness with bone status in children and adolescents from 11 to 16 years old. BMC Pediatr (2013) 0.76
Role of endocortical contouring methods on precision of HR-pQCT-derived cortical micro-architecture in postmenopausal women and young adults. Osteoporos Int (2015) 0.76
Relationship between Serum Levels of OPG and TGF- β with Decreasing Rate of BMD in Native Chinese Women. Int J Endocrinol (2013) 0.75
Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients? A prospective randomized multicenter international study. Clin Cases Miner Bone Metab (2017) 0.75
In vivo precision of three HR-pQCT-derived finite element models of the distal radius and tibia in postmenopausal women. BMC Musculoskelet Disord (2016) 0.75
Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis. Medicine (Baltimore) (2017) 0.75
Bone Density Screening and Re-screening in Postmenopausal Women and Older Men. Curr Osteoporos Rep (2015) 0.75
Brazilian pediatric reference data for quantitative ultrasound of phalanges according to gender, age, height and weight. PLoS One (2015) 0.75
Seasonal Variability in Vitamin D Levels No Longer Detectable in Primary Hyperparathyroidism. J Clin Endocrinol Metab (2015) 0.75
Precision of dual-energy X-ray absorptiometry of the knee and heel: methodology and implications for research to reduce bone mineral loss after spinal cord injury. Spinal Cord (2016) 0.75
Clinical challenges in the management of osteoporosis. Clin Interv Aging (2008) 0.75
Age-related bone turnover markers and osteoporotic risk in native Chinese women. BMC Endocr Disord (2014) 0.75
Bone Mineral Density Response from Teriparatide in Patients with Osteoporosis. HSS J (2017) 0.75
Comparison of spine and femur reference data in native Chinese women from different regions of China. Osteoporos Int (2005) 0.75
Optimal decision criterion for detecting change in bone mineral density during serial monitoring: a Bayesian approach. Osteoporos Int (2008) 0.75
Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax®) for osteoporosis treatment. PLoS One (2017) 0.75
Bone Mass in Boys with Autism Spectrum Disorder. J Autism Dev Disord (2017) 0.75
Cortical microstructure compensates for smaller bone size in young Caribbean Hispanic versus non-Hispanic white men. Osteoporos Int (2017) 0.75
Precision of bone density and micro-architectural properties at the distal radius and tibia in children: an HR-pQCT study. Osteoporos Int (2017) 0.75
Phantomless calibration of CT scans for measurement of BMD and bone strength-Inter-operator reanalysis precision. Bone (2017) 0.75
Global analysis of protein activities using proteome chips. Science (2001) 13.74
The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90
Large-scale analysis of the yeast genome by transposon tagging and gene disruption. Nature (1999) 9.87
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int (1998) 7.14
Organization of heterogeneous scientific data using the EAV/CR representation. J Am Med Inform Assoc (1999) 6.97
Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res (1997) 5.69
Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int (2014) 5.17
A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med (1999) 4.91
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest (1983) 4.53
Age and bone mass as predictors of fracture in a prospective study. J Clin Invest (1988) 4.46
Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry (2000) 4.44
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet (1976) 4.24
Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res (2000) 3.86
Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ (2001) 3.81
Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res (1997) 3.18
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med (2000) 3.16
Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11
Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab (1997) 3.00
An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int (2001) 2.94
The direct examination of three-dimensional bone architecture in vitro by computed tomography. J Bone Miner Res (1989) 2.89
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res (2001) 2.65
Screening for osteoporosis. Ann Intern Med (1990) 2.52
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone (2003) 2.51
Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA (1997) 2.46
The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int (1985) 2.44
Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine (Baltimore) (1968) 2.39
Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis. Am J Clin Nutr (1998) 2.37
Genetic factors in determining bone mass. J Clin Invest (1973) 2.35
Syndromes associated with deletion of the long arm of chromosome 18[del(18q)]. Am J Med Genet (1979) 2.34
Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int (2006) 2.34
Prevention of spinal osteoporosis in oophorectomised women. Lancet (1980) 2.34
TRIPLES: a database of gene function in Saccharomyces cerevisiae. Nucleic Acids Res (2000) 2.33
Post-lumbar puncture headaches: experience in 501 consecutive procedures. Neurology (1992) 2.30
Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med (1989) 2.30
Vitamin D and bone health in the elderly. Am J Clin Nutr (1982) 2.21
Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3' end of 16S rRNA. Proc Natl Acad Sci U S A (1981) 2.20
Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J Neurosci (1983) 2.18
Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab (2000) 2.14
Anabolic actions of parathyroid hormone on bone. Endocr Rev (1993) 2.13
Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res (1995) 2.12
Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11
Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab (2000) 2.09
Hypophosphatemic rickets with hypocalciuria following long-term treatment with aluminum-containing antacid. Bone (1991) 2.06
Drug use has declined among teenagers in United Kingdom. BMJ (2000) 2.02
Preventing injuries in children: cluster randomised controlled trial in primary care. BMJ (1999) 2.01
Urinary diagnosis of gonorrhoea and Chlamydia in men in remote aboriginal communities. Med J Aust (1997) 2.01
Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res (1997) 1.98
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol (1997) 1.97
Fracture history and bone loss in patients with MS. Neurology (1998) 1.97
Effect of diarrhoeal disease control on infant and childhood mortality in Egypt. Report from the National Control of Diarrheal Diseases Project. Lancet (1990) 1.95
Pathogenesis of osteoporosis. Lancet (1993) 1.93
Role of physical activity in the development of skeletal mass in children. J Bone Miner Res (1991) 1.86
Neuronal database integration: the Senselab EAV data model. Proc AMIA Symp (1999) 1.85
Radiography of the lumbar spine in primary care patients with low back pain: randomised controlled trial. BMJ (2001) 1.85
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res (1991) 1.82
The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol (1984) 1.80
Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J (1973) 1.79
Dietary exposure estimates of 30 elements from the UK Total Diet Study. Food Addit Contam (1999) 1.79
Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab (1995) 1.79
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int (2008) 1.76
Calcium nutrition and bone health in the elderly. Am J Clin Nutr (1982) 1.74
Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments. J Bone Miner Res (1997) 1.73
Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J Clin Invest (1997) 1.72
Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int (1997) 1.71
p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2. J Biol Chem (1996) 1.70
Cryogenic absolute radiometers as laboratory irradiance standards, remote sensing detectors, and pyroheliometers. Appl Opt (1990) 1.70
Proximal femur bone mineral levels of US adults. Osteoporos Int (1995) 1.69
Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest (1987) 1.68
Mental retardation with absent fifth fingernail and terminal phalanx. Am J Dis Child (1970) 1.67
Neonatal facial and cry responses to invasive and non-invasive procedures. Pain (1990) 1.64
The loss of bone mineral with aging and its relationship to risk of fracture. J Clin Invest (1975) 1.61
The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Calcif Tissue Int (2002) 1.61
Topical anesthesia during circumcision in newborn infants. JAMA (1993) 1.60
Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest (1996) 1.59
Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biol Psychiatry (2001) 1.59
Dietary calcium, protein, and phosphorus are related to bone mineral density and content in young women. Am J Clin Nutr (1998) 1.58
Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int (2004) 1.57
Profoundly abnormal initial physiologic and biochemical data cannot be used to determine futility in massively transfused trauma patients. J Trauma (2011) 1.57
Linkage of structure at the proximal femur to chromosomes 3, 7, 8, and 19. J Bone Miner Res (2003) 1.55
Genetic and clinical studies in 13 patients with the Wolf-Hirschhorn syndrome [del(4p)]. Hum Genet (1981) 1.55
High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology (1994) 1.54
Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4. Proc Natl Acad Sci U S A (1989) 1.54
Proceedings: The inhibitory effect of insulin on pinnal anaphylaxis in the mouse. Br J Pharmacol (1974) 1.54
PhenoDB: an integrated client/server database for linkage and population genetics. Comput Biomed Res (1996) 1.54
On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab (1999) 1.53
Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med (2000) 1.52
Progeston therapy for menstrually related aphthae. Int J Oral Surg (1978) 1.52
1997 UK Total Diet Study--dietary exposures to aluminium, arsenic, cadmium, chromium, copper, lead, mercury, nickel, selenium, tin and zinc. Food Addit Contam (2000) 1.51
The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab (1990) 1.51
Interdisciplinary health professional education: a historical review. Adv Health Sci Educ Theory Pract (2001) 1.50
Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clin Sci Mol Med (1978) 1.50
Differences in serum bone GLA protein with age and sex. Lancet (1984) 1.49